Tom Houben

2.0k total citations · 1 hit paper
40 papers, 1.0k citations indexed

About

Tom Houben is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Tom Houben has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Epidemiology and 12 papers in Physiology. Recurrent topics in Tom Houben's work include Liver Disease Diagnosis and Treatment (18 papers), Lipid metabolism and disorders (8 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). Tom Houben is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Lipid metabolism and disorders (8 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). Tom Houben collaborates with scholars based in Netherlands, Germany and Austria. Tom Houben's co-authors include Ronit Shiri‐Sverdlov, Tulasi Yadati, Albert V. Bitorina, Yvonne Oligschlaeger, Marten H. Hofker, Sofie M. A. Walenbergh, Tim Hendrikx, Marion J. Gijbels, Patrick J. van Gorp and Mike L. J. Jeurissen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tom Houben

39 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management

2020 299 citations Tulasi Yadati, Tom Houben et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Houben Netherlands	17	452	378	209	143	140	40	1.0k
Carlos A. Barrero United States	23	596 1.3×	211 0.6×	276 1.3×	186 1.3×	94 0.7×	49	1.4k
Alexander Sigrüener Germany	15	598 1.3×	251 0.7×	234 1.1×	91 0.6×	161 1.1×	23	999
You-kyung Choi United States	18	374 0.8×	571 1.5×	128 0.6×	193 1.3×	154 1.1×	46	1.4k
Denise E. Lackey United States	12	678 1.5×	379 1.0×	531 2.5×	203 1.4×	170 1.2×	14	1.4k
Kangmin Yang Taiwan	15	372 0.8×	227 0.6×	237 1.1×	224 1.6×	196 1.4×	31	1.2k
Jin Ye China	18	446 1.0×	245 0.6×	211 1.0×	90 0.6×	197 1.4×	63	1.0k
Yuki Abe Japan	15	369 0.8×	542 1.4×	286 1.4×	113 0.8×	191 1.4×	56	1.5k
Juanmin Zha China	15	553 1.2×	159 0.4×	171 0.8×	154 1.1×	164 1.2×	31	1.1k
Dina A. Schneider United States	7	391 0.9×	226 0.6×	252 1.2×	194 1.4×	110 0.8×	9	924

Countries citing papers authored by Tom Houben

Since Specialization

Citations

This map shows the geographic impact of Tom Houben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Houben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Houben more than expected).

Fields of papers citing papers by Tom Houben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Houben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Houben. The network helps show where Tom Houben may publish in the future.

Co-authorship network of co-authors of Tom Houben

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Houben. A scholar is included among the top collaborators of Tom Houben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Houben. Tom Houben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Houben, Tom, Albert V. Bitorina, Dennis M. Meesters, et al.. (2024). Plasma cathepsin D as an early indicator of alcohol-related liver disease. JHEP Reports. 6(9). 101117–101117.

Yadati, Tulasi, Gert B. Eijkel, Benjamin Balluff, et al.. (2024). Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction‐associated steatohepatitis. FEBS Journal. 292(7). 1781–1797. 1 indexed citations

Houben, Tom, et al.. (2023). Lipids in major depressive disorder: new kids on the block or old friends revisited?. Frontiers in Psychiatry. 14. 1213011–1213011. 6 indexed citations

Li, Mengying, Arthur Flohr Svendsen, Niels Kloosterhuis, et al.. (2022). Elevated granulocyte-colony stimulating factor and hematopoietic stem cell mobilization in Niemann-Pick type C1 disease. Journal of Lipid Research. 63(2). 100167–100167. 2 indexed citations

Yadati, Tulasi, Tom Houben, Albert V. Bitorina, et al.. (2021). Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice. Frontiers in Immunology. 12. 675535–675535. 17 indexed citations

Demais, Valérie, Izabela‐Cristina Stancu, Eugeniu Vasile, et al.. (2021). Glial contribution to cyclodextrin-mediated reversal of cholesterol accumulation in murine NPC1-deficient neurons in vivo. Neurobiology of Disease. 158. 105469–105469. 6 indexed citations

Houben, Tom, Tulasi Yadati, Marion J. Gijbels, et al.. (2021). Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment. Frontiers in Immunology. 12. 716357–716357. 11 indexed citations

Ding, Lingling, Yvonne Oligschlaeger, Ronit Shiri‐Sverdlov, & Tom Houben. (2020). Nonalcoholic Fatty Liver Disease. Handbook of experimental pharmacology. 270. 233–269. 9 indexed citations

Ding, Lingling, Gijs H. Goossens, Yvonne Oligschlaeger, et al.. (2019). Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans. Diabetologia. 63(2). 374–384. 20 indexed citations

10.

Houben, Tom, John Penders, Yvonne Oligschlaeger, et al.. (2019). Hematopoietic Npc1 mutation shifts gut microbiota composition in Ldlr−/− mice on a high-fat, high-cholesterol diet. Scientific Reports. 9(1). 14956–14956. 3 indexed citations

11.

Houben, Tom, Yvonne Oligschlaeger, Hellen Steinbusch, et al.. (2019). Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease. Frontiers in Immunology. 9. 3089–3089. 9 indexed citations

12.

Houben, Tom, Yvonne Oligschlaeger, Tim Hendrikx, et al.. (2017). Cathepsin D regulates lipid metabolism in murine steatohepatitis. Scientific Reports. 7(1). 3494–3494. 48 indexed citations

13.

Janssen, Aafke W. F., Tom Houben, Saeed Katiraei, et al.. (2017). Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. Journal of Lipid Research. 58(7). 1399–1416. 97 indexed citations

14.

Houben, Tom, Yvonne Oligschlaeger, Albert V. Bitorina, et al.. (2017). Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation. Scientific Reports. 7(1). 12550–12550. 19 indexed citations

15.

Chanda, Dipanjan, Jieyi Li, Yvonne Oligschlaeger, et al.. (2016). MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. Experimental & Molecular Medicine. 48(9). e258–e258. 16 indexed citations

16.

Li, Jieyi, Dipanjan Chanda, Patrick J. van Gorp, et al.. (2016). Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model. PLoS ONE. 11(9). e0163843–e0163843. 15 indexed citations

17.

Jeurissen, Mike L. J., Sofie M. A. Walenbergh, Tom Houben, et al.. (2016). Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice. PLoS ONE. 11(11). e0167199–e0167199. 4 indexed citations

18.

Houben, Tom, Eelke Brandsma, Sofie M. A. Walenbergh, Marten H. Hofker, & Ronit Shiri‐Sverdlov. (2016). Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(4). 416–429. 25 indexed citations

19.

Walenbergh, Sofie M. A., Tom Houben, Tim Hendrikx, et al.. (2015). Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation. The American Journal of Gastroenterology. 110(3). 462–470. 37 indexed citations

20.

Brandsma, Eelke, Tom Houben, Jingyuan Fu, Ronit Shiri‐Sverdlov, & Marten H. Hofker. (2015). The immunity–diet–microbiota axis in the development of metabolic syndrome. Current Opinion in Lipidology. 26(2). 73–81. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact